media release moderna lonza mrna-1273/media/files/japan/news/200501... · 2020. 8. 3. ·...
TRANSCRIPT
Lonza Group Ltd│ Muenchensteinerstrasse38│CH-4002Basel │Switzerland +41 613168111 │ www.lonza.com │ [email protected]
MEDIA RELEASE
Moderna Lonza
mRNA-1273
10
2020 6
mRNA-1273 2020 7 Lonza
Lonza
Moderna Stéphane Bancel
Lonza
Moderna mRNA-1273
10
Lonza
10 mRNA-
1273
Lonza CEO Albert M. Baehny
Moderna
Moderna mRNA-1273 Moderna
Lonza Group Ltd│ Muenchensteinerstrasse38│CH-4002Basel │Switzerland +41 613168111 │ www.lonza.com │ [email protected]
2020 5 1 ( ) –
RNA (mRNA)
Moderna, Inc., (Nasdaq: MRNA) Lonza Ltd.
(SIX:LONN) (SARS-CoV-2) Moderna mRNA
(mRNA-1273) Moderna 10
mRNA-1273 Lonza
2020 6 2020 7
Lonza U.S mRNA-1273 Lonza
50μg 10 mRNA-1273
Lonza Moderna
mRNA-1273
2020 4 16
Biomedical Advanced Research and Development Authority (BARDA) Moderna
Lonza U.S BARDA
mRNA-1273 50
Lonza
Moderna
Moderna 2020 4 27 1
(FDA) mRNA-1273 2 IND
(Investigational New Drug) ( ) Moderna
2 FDA
2020 2 mRNA-1273 28
2
50μg 250μg
18 55 (n=300) 55 (n=300) 2 600
2 12
mRNA-1273
mRNA-1273 Spike (S) SARS-CoV-2 mRNA
NIH (NIAID)
(VRC) Moderna Coalition for Epidemic
Lonza Group Ltd│ Muenchensteinerstrasse38│CH-4002Basel │Switzerland +41 613168111 │ www.lonza.com │ [email protected]
Preparedness Innovations 2020 2 7
42 2 24 NIH mRNA-
1273 NIAID 1 1 63
3 16 SARS-CoV-2
NIAID 1
mRNA-1273 1
(IND) 2020 3 16 1
3 (25μg 100μg 250μg) 18 55 45
6 : (56 70 ) 3
(71 ) 3 18 55
Moderna
Moderna
Moderna
1,400
Moderna
1
mRNA
mRNA 1
mRNA
Moderna
Moderna 9
:
• (RSV) (Merck mRNA-
1777 mRNA-1172 V172)
• RSV (mRNA-1345)
Lonza Group Ltd│ Muenchensteinerstrasse38│CH-4002Basel │Switzerland +41 613168111 │ www.lonza.com │ [email protected]
• (hMPV) 3 (PIV3)
(mRNA-1653)
• (SARS-CoV-2) ( mRNA-1273)
• H7N9 (mRNA-1851)
• (CMV) (mRNA-1647)
• (mRNA-1893 BARDA)
• (EBV) (mRNA-1189)
Moderna 7 (H10N8 H7N9 RSV
hMPV/PIV3 CMV ) 1
Moderna CMV 2
1 Moderna (mRNA-1893) 2019 8 FDA Fast
Track
Lonza
Lonza
Lonza
1897 Lonza 35 120
15,500 Lonza
2019 59
CORE EBITDA 16 www.Lonza.com
Twitter@LonzaGroup Facebook@LonzaGroupAG
Lonza Group Ltd│ Muenchensteinerstrasse38│CH-4002Basel │Switzerland +41 613168111 │ www.lonza.com │ [email protected]
Moderna
Moderna RNA (mRNA)
mRNA
mRNA
Moderna
Moderna
AstraZeneca PLC Merk & Co.,Inc.
Defense Advanced Research Projects Agency (DARPA)
(HHS) Office of the Assistant Secretary for Preparedness and
Response (ASPR) Biomedical Advanced Research and Development Authority
(BARDA) Moderna 5
Science 10
www.modenatx.com
- Lonza
Media: Dr. Sanna Fowler Head of External Communications +41 79 539 0615 [email protected] Victoria Morgan Head of Corporate Communications +41 79 599 6260 [email protected] Investor Relations: Dirk Oehlers Investor Relations Director +41 79 421 1609 [email protected]
Lonza Group Ltd│ Muenchensteinerstrasse38│CH-4002Basel │Switzerland +41 613168111 │ www.lonza.com │ [email protected]
- Moderna
Media: Colleen Hussey Senior Manager, Corporate Communications 203-470-5620 [email protected] Dan Budwick 1AB 973-271-6085 [email protected] Investors: Lavina Talukdar Head of Investor Relations 617-209-5834 [email protected]
Lonza
SGX-ST Lonza
SGXST SGXST 217
751
Lonza
Lonza
Lonza
Lonza Group Ltd 2020 5 1
Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna’s Vaccine (mRNA-1273) Against Novel Coronavirus